By introducing the Virtual Simulation-based Pharmaceutical Manufacturing Training Program, which is exclusive for pharmacy students, the Karnataka State Pharmacy Council (KSPC) has made a major advancement in pharmacy education
In a Phase III research of ART-123, Asahi Kasei Pharma has begun trial drug administration in Japan to avoid symptoms associated with chemotherapy-induced peripheral neuropathy. This statement comes after positive results from previous Phase I and II
Telangana Chief Minister A. Revanth Reddy has rolled out an ambitious proposal to make Telangana the foremost state in India as a health tourism State. In his remarks during the launch...
In a recent response to the reports in Karnataka's Hassan district claiming COVID-19 vaccines led to heart attack deaths, the Indian Pharmaceutical Alliance (IPA) expressed its strong defense of both vaccine safety and the integrity of regulatory...
In the most significant move towards the standardization of language across the Indian healthcare system, the National Commission for Allied and Healthcare Professions (NCAHP) set up by the Union Health Ministry
Alembic Pharmaceuticals has entered into a definitive agreement to acquire UK-based Utility Therapeutics Ltd. for USD 12 million, a strategic expansion into the branded anti-infective space in the United States...
In a major development for India's drug regulatory system, the Delhi High Court has ordered the Drug Controller General of India (DCGI) to respond within three months to a Public Interest Litigation (PIL) that challenges the approval of...
The Indian pharmaceutical industry achieved a worthwhile of 7.38 with April-May FY26, which recorded $4.961 billion in Indian pharmaceutical exports compared to the same period in FY25, showing a healthy growth rate, as reported by Pharmex...
Lyfius Pharma Private Limited, a fully owned step-down subsidiary of Aurobindo Pharma, has announced the resumption of production at its Penicillin-G manufacturing facility in Kakinada, Andhra Pradesh
Cadila Pharmaceuticals has launched Bilacad Dex Syrup, a fixed-dose combination for meeting the mounting burden of respiratory and allergic conditions.